CI Investments Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.19M | Sell |
3,611
-2,441
| -40% | -$831K | 0.01% | 418 |
|
|
2025
Q4 | $2.41M | Sell |
6,052
-1,172
| -16% | -$519K | 0.01% | 366 |
|
|
2025
Q3 | $3.29M | Buy |
7,224
+3,109
| +76% | +$1.27M | 0.01% | 327 |
|
|
2025
Q2 | $1.34M | Buy |
4,115
+1,894
| +85% | +$524K | 0.01% | 393 |
|
|
2025
Q1 | $600K | Sell |
2,221
-1,263
| -36% | -$325K | ﹤0.01% | 496 |
|
|
2024
Q4 | $820K | Sell |
3,484
-113
| -3% | -$29.7K | ﹤0.01% | 450 |
|
|
2024
Q3 | $989K | Sell |
3,597
-25
| -0.7% | -$6.51K | ﹤0.01% | 413 |
|
|
2024
Q2 | $880K | Sell |
3,622
-269
| -7% | -$42.5K | ﹤0.01% | 405 |
|
|
2024
Q1 | $582K | Buy |
3,891
+1,540
| +66% | +$257K | ﹤0.01% | 464 |
|
|
2023
Q4 | $450K | Sell |
2,351
-297
| -11% | -$50.6K | ﹤0.01% | 465 |
|
|
2023
Q3 | $469K | Sell |
2,648
-337
| -11% | -$64.3K | ﹤0.01% | 446 |
|
|
2023
Q2 | $567K | Buy |
2,985
+1,355
| +83% | +$269K | ﹤0.01% | 432 |
|
|
2023
Q1 | $327K | Buy |
1,630
+891
| +121% | +$187K | ﹤0.01% | 509 |
|
|
2022
Q4 | $176K | Buy |
739
+345
| +88% | +$73.6K | ﹤0.01% | 630 |
|
|
2022
Q3 | $79K | Buy |
394
+136
| +53% | +$25.9K | ﹤0.01% | 738 |
|
|
2022
Q2 | $38K | Sell |
258
-434
| -63% | -$61.6K | ﹤0.01% | 866 |
|
|
2022
Q1 | $113K | Buy |
692
+49
| +8% | +$7.46K | ﹤0.01% | 831 |
|
|
2021
Q4 | $109K | Buy |
643
+126
| +24% | +$23.4K | ﹤0.01% | 875 |
|
|
2021
Q3 | $98K | Buy |
+517
| New | +$97K | ﹤0.01% | 862 |
|
|
2020
Q3 | – | Sell |
-2,036
| Closed | -$302K | – | 932 |
|
|
2020
Q2 | $302K | Buy |
+2,036
| New | +$274K | ﹤0.01% | 457 |
|
|
2020
Q1 | – | Sell |
-3,220
| Closed | -$371K | – | 566 |
|
|
2019
Q4 | $371K | Buy |
+3,220
| New | +$321K | ﹤0.01% | 529 |
|
Other funds holding ALNY
VPM
VCM
